The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Biobankonomics: Developing a Sustainable Business Model Approach for the Formation of a Human Tissue Biobank
Open accessAbstract
The preservation of high-quality biospecimens and associated data for research purposes is being performed in variety of academic, government, and industrial settings. Often these are multimillion dollar operations, yet despite these sizable investments, the economics of biobanking initiatives is not well understood. Fundamental business principles must be applied to the development and operation of such resources to ensure their long-term sustainability and maximize their impact. The true costs of developing and maintaining operations, which may have a variety of funding sources, must be better understood. Among the issues that must be considered when building a biobank economic model are: understanding the market need for the particular type of biobank under consideration and understanding and efficiently managing the biobank's "value chain," which includes costs for case collection, tissue processing, storage management, sample distribution, and infrastructure and administration. By using these value chain factors, a Total Life Cycle Cost of Ownership (TLCO) model may be developed to estimate all costs arising from owning, operating, and maintaining a large centralized biobank. The TLCO approach allows for a better delineation of a biobank's variable and fixed costs, data that will be needed to implement any cost recovery program. This article represents an overview of the efforts made recently by the National Cancer Institute's Office of Biorepositories and Biospecimen Research as part of its effort to develop an appropriate cost model and cost recovery program for the cancer HUman Biobank (caHUB) initiative. All of these economic factors are discussed in terms of maximizing caHUB's potential for long-term sustainability but have broad applicability to the wide range of biobanking initiatives that currently exist.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Path to Personalized Medicine
Hamburg, M. A., & Collins, F. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1006304 · Cited by 1,970
Cited by
Shabihkhani, M., Lucey, G. M., Wei, B., Mareninov, S., Lou, J. J., Vinters, H. V., Singer, E. J., Cloughesy, T. F., & Yong, W. H. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.01.002 · Cited by 283
A review of the key issues associated with the commercialization of biobanks
Caulfield, T., Burningham, S., Joly, Y., Master, Z., Shabani, M., Borry, P., Becker, A., Burgess, M., Calder, K., Critchley, C., et al. (2014) · Journal of Law and the Biosciences · doi:10.1093/jlb/lst004 · Cited by 126
Nisbet, M. C., & Fahy, D. (2013) · BMC Medical Ethics · doi:10.1186/1472-6939-14-10 · Cited by 35
Metadata
- Authors
- Vaught, J., Rogers, J., Carolin, T., & Compton, C.
- Venue
- JNCI Monographs
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-06-01
- Volume
- 2011
- Issue
- 42
- Pages
- 24-31
- ISSN
- 1052-6773 (ISSN-L)
- 1745-6614
- OpenAlex
- W2156144465
- Cited by
- 184
- References
- 1
- FWCI
- 18.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biobankonomics: Developing a Sustainable Business Model Approach for the Formation of a Human Tissue Biobank. https://app.cochat.ai/papers/10.1093/jncimonographs/lgr009
- The paper
- Vaught, J., Rogers, J., Carolin, T., & Compton, C. (2011). Biobankonomics: Developing a Sustainable Business Model Approach for the Formation of a Human Tissue Biobank. JNCI Monographs. https://doi.org/10.1093/jncimonographs/lgr009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.